ArticleFrontiers in molecular biosciences2023

A pan-cancer analysis reveals CHD1L as a prognostic and immunological biomarker in several human cancers.

Mohamed A Soltan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.